Plus, the Trump administration is seeking a third coronavirus stimulus package, the WHO warns that the virus can in some cases survive in the air, and Cisco said that there have been 5.5 billion meeting minutes for its Webex video conferencing platform since the start of the month.
Read MorePlus, airlines could be in danger, and Regeneron and Sanofi are soon to begin human trials on a treatment for COVID-19.
Read MorePlus, Congress and the Trump Administration are nearing a coronavirus aid package, and the Fed began buying Treasurys.
Read MoreBuy Target – $5.50 or better Sell Target – TradersPro Sell Signal AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company’s products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat […]
Read MorePlus, Italy announced a nation-wide lockdown in an attempt to slow the spread of the coronavirus, Saudi Arabia and Russia escalated their oil price war, and Dick’s Sporting Goods is removing guns from another 440 stores.
Read MoreBuy Target – $3.75 or better Sell Target – TradersPro Sell Signal Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, radiation oncology, […]
Read MorePlus, 30-year mortgage rates have fallen to their lowest level ever amid coronavirus fears, and an analyst says Gilead’s COVID-19 treatment only has a 50/50 chance, at best, of proving successful.
Read MoreBuy Target – $10.75 or better Sell Target – TradersPro Sell Signal BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various partnered […]
Read MorePlus, activity in the U.S. services sector accelerated in February, GE said the coronavirus will impact Q1 earnings, and Arcturus Therapeutics shares are on the rise after the company joins the quest to find a COVID-19 vaccine.
Read MoreBuy Target – $21.00 or better Sell Target – TradersPro Sell Signal Cue Biopharma, Inc., a biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate CUE-101, a protein biologic designed to target and activate […]
Read MorePlus, Pfizer announced it is initiating a program to screen antiviral drugs in its pipeline to identify possible treatments for the coronavirus, Target and Kohl’s reported earnings, and Thermo Fisher is buying Qiagen.
Read MorePlus, manufacturing activity slumped in February, and Costco could see a sales boost from the coronavirus.
Read MoreBuy Target – $11.00 or better Sell Target – TradersPro Sell Signal Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, focusing on developing therapies for pets. Its product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. The company offers Mirataz, a mirtazapine transdermal ointment for the management […]
Read MorePlus, Home Depot and Macy’s topped earnings estimates, while Shake Shack disappointed.
Read MorePlus, Warren Buffett called Apple “the best business I know in the world,” Intuit is buying Credit Karma, and Walls Fargo has agreed to pay $3 billion to settle the criminal and civil cases against it.
Read More